Home > Cluster Organisations > Pharmapolis Debrecen Innovative Pharmaceutial Cluster

Pharmapolis Debrecen Innovative Pharmaceutial Cluster

Primary tabs

Printer-friendly versionPrinter-friendly version
General Information
The date when the cluster organisation was established: 
Monday, 25 August, 2008
Number of staff in the management team of the cluster organisation : 
1-5
Regions: 
Észak-Alföld
Other Label: 
Accredited Innovation Cluster
Membership to other networks/partnerships: 
Cluster Management Team: 
NameSurnamePositionTelephoneEmail
Éva
dr. Skultéti
Cluster Manager
+36302297899
skulteti.eva@hbkik.hu
Languages spoken: 
English
Sectoral and Industrial Focus
Sectoral Industries: 
Biopharmaceuticals
Technology fields: 
Medical Research
Medical Technology / Biomedical Engineering
S3 EU priority areas: 
Human health activities (medical services)
Basic pharmaceutical products & pharmaceutical preparations
Emerging industries: 
Biopharmaceuticals
Composition of the cluster
Total number of members: 
24
Number of SME members: 
15
Number of larger company members: 
3
Number of research organisations/universities/technology centres: 
3
Number of other ecosystem actors : 
3
Entrepreneurship and scale-up support facilities in the cluster's ecosystem (see "Organisation type"): 
Name and link of major players: 
NameWebsiteType
Richter Gedeon Plc.
Larger Company
University Debrecen
University
Chamber of Commerce and Industry of Hajdú-Bihar
Cluster Strategy
Mission/Objectives: 

The establishment of the Pharmapolis Innovative Pharmaceautical Cluster represents the general intensions of the economic sectors dominantly present in Debrecen and the stakeholders of the pharmaceautical industry as well as the City Council of Debrecen of County Rank, the Chamber of Commerce and Industry of Hajdú-Bihar and the University of Debrecen on the basis of which they wish to cooperate on the promotion of industrial networking supported by the makings of the region. The name of ‘Pharmapolis’ has been clearly apparent in the collaborations between the city and the university since 2005 when the City Council of Debrecen and the University of Debrecen together with several small and medium enterprises brought about the Pharmapolis Debrecen Ltd. This economic company together with the Richter Gedeon Pharmaceautical Company, which is the most important pharmaceautical stakeholder of the cluster, carry out closely aligned R+D activities in the field –primarily – clinical researches. The name of ‘Pharmapolis’ is also used to refer to the Debrecen Pole Program.

The objective of the Pharmapolis Cluster is versatile; it wishes to strengthen the less developed elements in the innovative chain of the Hungarian pharmaceautical industry as it is required by the export interests of economic stakeholders and on the other hand, it also wishes to contribute to the improvement of European innovative capacities. They wish to reach these goals by adopting the pharmaceautically-specified elements of the European Technological Platforms.

Do you have a formalised strategy?: 
Yes
Do you have a specific strategy focus that addresses internationalisation ?: 
No
Services
Support services provided: 
Access to the European Internal market
Internationalisation support (= Access to third countries markets)
Access to technology services
Facilitation of collaboration between members
Cooperation Activities
International Cooperation
The main countries targeted by the cluster organisation: 
India
Mexico
Our cluster organisation undertook the following international activities to support our members: 
Participation at missions/events/study visits/fairs
Trans-national Cooperation
The main countries targeted by the cluster organisation: 
Bosnia and Herzegovina
Germany
Romania
Russian Federation
Spain
Our cluster organisation undertook the following trans-national activities to support our members: 
Support to collaborative activities/etc.
Which clusters do you collaborate with?: 
Imago-Mol
Pharmagora
Innovative Food Cluster
MSE Cluster
SPA Cluster
Support Programmes
Participation in Funded Support Programmes: 
European ProgrammesProject Name
FP7
CIP/COSME

AMI4EUROPE